Aldridge C, Behrend E N, Martin L G, Refsal K, Kemppainen R J, Lee H P, Chciuk K
Department of Clinical Sciences, Auburn University, Auburn, AL.
Department of Pathobiology and Diagnostic Investigation, Michigan State University, Lansing, MI.
J Vet Intern Med. 2015 May-Jun;29(3):862-8. doi: 10.1111/jvim.12575. Epub 2015 Apr 1.
Iatrogenic hypothyroidism (IH) after treatment of hyperthyroidism can impair renal function. No study compared the efficacy of measurement of serum free thyroxine by equilibrium dialysis (fT4ed) or thyroid-stimulating hormone (TSH) concentrations for monitoring cats receiving methimazole.
To (1) compare the ability of total T4 and fT4ed concentrations in conjunction with TSH to define thyroid function in hyperthyroid cats receiving methimazole, (2) determine the prevalence of IH in cats receiving methimazole, and (3) examine the relationship between thyroid axis hormones and serum creatinine concentration.
One hundred and twenty-five serum samples from hyperthyroid cats receiving methimazole and total T4 concentrations ≤3.9 μg/dL.
Total T4, fT4ed, and TSH concentrations were measured to evaluate thyroid status and serum creatinine concentration was measured to assess renal function. A low total T4 or fT4ed concentration in combination with an increased TSH concentration defined IH.
Forty-one cats (33%) had increased TSH concentrations. Of cats with total T4 and fT4ed concentrations below the reference range, 68% and 73%, respectively, had TSH concentrations above the reference range. Only 18% of cats with a normal TSH concentration had an increased serum creatinine concentrations as compared to 39% of those with increased TSH concentrations (P < .001).
Free T4ed does not identify more cats with potential IH as compared to total T4. The IH prevalence was approximately 20%. Measurement of TSH may be more helpful in indicating that azotemia, if present, is at least in part related to IH. Investigation is needed to define TSH assay utility in identifying possible subclinical IH.
甲状腺功能亢进症治疗后的医源性甲状腺功能减退(IH)会损害肾功能。尚无研究比较平衡透析法测定血清游离甲状腺素(fT4ed)或促甲状腺激素(TSH)浓度对接受甲巯咪唑治疗的猫进行监测的效果。
(1)比较总T4和fT4ed浓度联合TSH对接受甲巯咪唑治疗的甲状腺功能亢进猫甲状腺功能的界定能力;(2)确定接受甲巯咪唑治疗的猫中IH的患病率;(3)研究甲状腺轴激素与血清肌酐浓度之间的关系。
来自接受甲巯咪唑治疗且总T4浓度≤3.9μg/dL的甲状腺功能亢进猫的125份血清样本。
测定总T4、fT4ed和TSH浓度以评估甲状腺状态,测定血清肌酐浓度以评估肾功能。总T4或fT4ed浓度低且TSH浓度升高定义为IH。
41只猫(33%)TSH浓度升高。总T4和fT4ed浓度低于参考范围的猫中,分别有68%和73%的TSH浓度高于参考范围。TSH浓度正常的猫中只有18%血清肌酐浓度升高,而TSH浓度升高的猫中这一比例为39%(P<0.001)。
与总T4相比,fT4ed并不能识别出更多有潜在IH的猫。IH患病率约为20%。TSH测定可能更有助于表明如果存在氮质血症,至少部分与IH有关。需要进行研究以确定TSH检测在识别可能的亚临床IH中的效用。